Field Rachel D, Jakus Margaret A, Chen Xiaoyu, Human Kelia, Zhao Xuanhe, Chitnis Parag V, Sia Samuel K
Department of Biomedical Engineering, Columbia University, 351 Engineering Terrace, 1210 Amsterdam Avenue, New York, NY 10027, USA.
Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Angew Chem Int Ed Engl. 2022 May 9;61(20):e202116515. doi: 10.1002/anie.202116515. Epub 2022 Mar 16.
Traditional implanted drug delivery systems cannot easily change their release profile in real time to respond to physiological changes. Here we present a microfluidic aqueous two-phase system to generate microcapsules that can release drugs on demand as triggered by focused ultrasound (FUS). The biphasic microcapsules are made of hydrogels with an outer phase of mixed molecular weight (MW) poly(ethylene glycol) diacrylate that mitigates premature payload release and an inner phase of high MW dextran with payload that breaks down in response to FUS. Compound release from microcapsules could be triggered as desired; 0.4 μg of payload was released across 16 on-demand steps over days. We detected broadband acoustic signals amidst low heating, suggesting inertial cavitation as a key mechanism for payload release. Overall, FUS-responsive microcapsules are a biocompatible and wirelessly triggerable structure for on-demand drug delivery over days to weeks.
传统的植入式给药系统难以实时轻松改变其释放曲线以应对生理变化。在此,我们展示了一种微流控双水相系统,用于生成微胶囊,该微胶囊可在聚焦超声(FUS)触发下按需释放药物。双相微胶囊由水凝胶制成,其外相为混合分子量(MW)的聚乙二醇二丙烯酸酯,可减轻药物过早释放,内相为高MW葡聚糖并含有药物,该内相在FUS作用下会分解。微胶囊中的化合物释放可按需触发;在数天内,通过16个按需步骤释放了0.4μg的药物。我们在低加热状态下检测到宽带声信号,表明惯性空化是药物释放的关键机制。总体而言,FUS响应性微胶囊是一种生物相容性且可无线触发的结构,可在数天至数周内按需给药。